Top Health Tech Companies in Pune (58)
Cencora is a leading pharmaceutical solutions organization centered on improving the lives of people and animals everywhere. With 46,000+ global team members, we have the opportunity to make a positive impact on healthcare in communities everywhere. Our team members are empowered to activate their careers through a collective of tools and resources designed to support individual career interests and...
Cencora's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results show steady top-line expansion: FY2025 rose 9.3% and FY2026 quarters continued to grow in the mid‑single digits, with full‑year guidance at 4%–6%. Management indicates both U.S. and International Healthcare Solutions are expected to expand, sustaining momentum.
Profitability: Adjusted operating income and EPS increased at double‑digit rates (e.g., FY2025 AOI +15.8% and EPS +16.3%, with Q3 FY2026 EPS +12%), and guidance points to 13%–14% adjusted operating income growth. Outlook also includes solid adjusted free cash flow of around $3.0B.
Strong Market Position & Advantage: The company is consistently portrayed as one of the three dominant U.S. pharmaceutical distributors, reflecting scale, reach, and entrenched relationships. This position supports durable volumes in specialty categories and international distribution.
Zocdoc is the tech company at the beginning of a better healthcare experience. Each month, millions of patients use Zocdoc to find in-network neighborhood doctors, instantly book appointments online, see what other real patients have to say, get reminders for upcoming appointments and preventive check-ups, fill out their paperwork online, and more.
Zocdoc's Top Stability & Growth Strengths
Profitability: Company materials describe sustained annual profitability since 2023 and cash-flow positivity, pairing growth with disciplined financial health. It also reports meeting efficiency benchmarks, noting it exceeded the Rule of 40 in 2025.
Strong Revenue Growth: Disclosures point to multi-year revenue expansion with momentum described as accelerating, indicating robust top-line performance. This growth is presented alongside expanding provider and patient scale.
Strategic Partnerships: The platform is increasingly embedded across external channels through integrations with Healthgrades, Yelp, Google Gemini, and payer portals, broadening distribution and demand capture. These arrangements signal deeper ecosystem reach beyond the core marketplace.
Optum, part of the UnitedHealth Group family of businesses, is a global organization that delivers care, aided by technology to help millions of people live healthier lives. The work you do with our team will directly improve health outcomes by connecting people with the care, pharmacy benefits, data and resources they need to feel their best. Here, you will find...
.jpg)
Optum's Top Stability & Growth Strengths
Strong Revenue Growth: Optum’s consolidated revenue expanded from $253.0B in 2024 to $270.6B in 2025, indicating continued top-line growth. Multi‑year reporting also highlights ongoing increases at the consolidated level even as segment performance diverges.
Diversified Revenue Streams: Performance is spread across three businesses, with Optum Rx delivering substantial gains, Optum Insight growing modestly, and Optum Health contracting. This mix shows pharmacy and technology services helping sustain overall scale despite softness in care delivery.
Cost & Operational Efficiency: Operating performance improved in 2026 as Optum’s operating income rose year over year to about $4B in Q2 alongside reported gains in technology and clinical operations. UnitedHealth also raised its 2026 adjusted EPS outlook, signaling confidence in execution.
ZS is a management consulting and technology firm that partners with companies to improve life and how we live it. We transform ideas into impact by bringing together data, science, technology and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 15,000+ employees in over 40 offices worldwide.
ZS's Top Stability & Growth Strengths
Strong Hiring & Retention: Hiring and headcount are expanding, with disclosures of 15,000+ global employees, thousands of new hires, and third‑party estimates indicating continued workforce growth. Available evidence also points to active internal mobility and a recent increase in active job postings.
Market Expansion: Geographic and client footprints are broadening, with 40+ offices and 1,700+ customers across 170+ countries alongside concrete investments in new and expanded locations such as Hyderabad and Kingston. These moves indicate scaling delivery capacity in major capability centers and new regions.
Innovation-Driven Growth: The offering mix is shifting toward AI, data, technology, and platforms, including proprietary solutions and product capabilities. Strategic moves such as Salesforce-focused acquisitions and collaborations, plus a Tulip solution partnership, extend capabilities beyond traditional consulting.
Welcome to Noccarc - a revolutionary medical device company at the forefront of healthcare innovation. Our smart medical devices are just the beginning of our mission to transform the healthcare industry through technology. With our smart devices and digital platform, we're empowering hospitals and doctors to provide better care to patients than ever before. At Noccarc, we're passionate about making...
WellSky is a technology company advancing human wellness worldwide. Our software and professional services address the continuum of health and social care — helping businesses, organizations, and communities solve tough challenges, improve collaboration for growth, and achieve better outcomes through predictive insights that only WellSky solutions can provide. WellSky serves more than 20,000 client sites around the world — including...
WellSky's Top Stability & Growth Strengths
Strong Market Position & Advantage: Feedback suggests WellSky sits in the top competitive cohort for enterprise post‑acute platforms and differentiates through a broad, cross‑setting footprint. Its CarePort‑enabled transitions network linking thousands of acute entities to 130,000+ post‑discharge providers underpins scale and influence.
Strategic Partnerships: Feedback suggests expanded collaborations with Google Cloud, Centene/WellCare programs, and Unison Health Services are extending distribution and data/AI capabilities. These alliances signal ongoing platform investment and ecosystem reach.
Innovation-Driven Growth: Feedback suggests recent AI‑powered referral intake, a new home health Point of Care app, and ambient documentation via Scribe are driving product expansion and adoption. Reported use at hundreds of agencies indicates traction for AI embedded in workflows.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with...
Roche's Top Stability & Growth Strengths
Strong Market Position & Advantage: Roche is the global leader in in‑vitro diagnostics and remains a top‑tier biopharma with a significant oncology footprint. The dual Pharmaceuticals–Diagnostics model is a strategic differentiator at scale.
Strong Revenue Growth: Group sales rose 7% at constant exchange rates in 2025 and 6% at CER in Q1 2026, with both divisions contributing. Guidance for 2026 indicates continued mid–single‑digit CER growth.
Profitability: Profitability improved in 2025 alongside sales, with higher IFRS net income and core EPS growth. Management pointed to capacity to keep investing while rewarding shareholders.
.png)
athenahealth strives to cure complexity and simplify the practice of healthcare. Our innovative technology includes electronic health records, revenue cycle management, and patient engagement solutions that help healthcare providers, administrators, and practices eliminate friction for patients while getting paid efficiently. athenahealth partners with practices with purpose-built software backed by expertise to produce the insights needed to drive better clinical and...
athenahealth's Top Stability & Growth Strengths
Strong Market Position & Advantage: Strong market positioning is reinforced by repeated “Best in KLAS” recognition and being described as a leader in ambulatory EHR/practice management for independent physician practices. Broad adoption among ambulatory providers and large-scale deployments support a durable competitive edge in its core segment.
Innovation-Driven Growth: Innovation-driven momentum is emphasized through an AI-native roadmap and multiple AI feature launches across EHR, documentation, patient communications, and revenue-cycle workflows. Interoperability initiatives (including TEFCA migration) further strengthen platform stickiness and scalability.
Resilient & Sustainable Growth: Resilience is reflected in continued organic growth and expectations of mid- to high-single-digit revenue increases despite temporary disruptions such as the 2024 Change Healthcare cyberattack. Forecasts for expanding EBITDA and a shift to positive free operating cash flow in 2025 support a stable growth trajectory.
A first of its kind, Pharmarack is a commerce to insights technology company uniquely anchored by 17 leading Indian Pharma companies accounting for more than 50%+ the industry focused on strengthening the pharmaceutical distribution and supply chain ecosystem. Incidentally, not only is Pharmarack India’s largest Pharma B2B commerce platform but also India’s largest B2B commerce Platform in terms of GMV with...
Smith+Nephew is a global medical technology company. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential. From our first employee and founder, T.J. Smith, to our team today, it’s our people who make Smith+Nephew a unique place. Yes, we love...
Smith+Nephew is a global medical technology company. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential. From our first employee and founder, T.J. Smith, to our team today, it’s our people who make Smith+Nephew a unique place. Yes, we love...
Smith & Nephew's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results show mid-single-digit underlying growth through 2024–2025, with management reiterating guidance for continued growth in 2026. Early 2026 updates indicate broad-based contributions across units despite some subsegment variability.
Profitability: Trading profit and margins improved, supported by execution of the 12‑Point Plan and the transition to the RISE strategy. Management is guiding to further profit growth alongside higher returns.
Healthy Cash Flow: Free cash flow strengthened in 2025 with guidance for robust generation in 2026. Share repurchases completed and newly announced buybacks signal confidence and disciplined capital allocation.
Velsera connects healthcare and life sciences to reveal the true promise of precision medicine — a continuous flow of knowledge between researchers, scientists, and clinicians around the world, fueling innovation and creating insights that radically improve human health. Our goal is to use data to radically improve healthcare globally and create value through multiomics and insights. If you’re interested in learning more...
As India's leading integrated healthcare company, Practo has been on a mission to make quality healthcare accessible and affordable to all by connecting the entire healthcare ecosystem including patients, doctors, clinics, hospitals, pharmacies, and diagnostics in a seamless and cohesive manner. Practo effortlessly streamlines the patient's healthcare journey right from primary healthcare, viz. finding and booking an appointment with verified...
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together...
Syneos Health's Top Stability & Growth Strengths
Strong Market Position & Advantage: Company materials and third‑party recognition portray a fully integrated CRO/CCO with leadership status, including widespread involvement in recent FDA/EMA novel therapies and recognition as a leading pharmacovigilance provider.
Strategic Partnerships: Recent collaborations with Microsoft and KX are positioned to enable AI‑driven efficiencies across clinical and commercial operations, with reported improvements in cycle times supporting operational scalability.
Investor Backing & Capital Strength: The 2025 take‑private by investment groups (including Elliott and Veritas) provides financial sponsorship to pursue tech‑enabled growth and operational repositioning.
Cotiviti is a leading solutions and analytics company that is reshaping the economics of healthcare, helping its clients uncover new opportunities to unlock value. Cotiviti’s solutions are a critical foundation for healthcare payers in their mission to lower healthcare costs and improve quality through higher performing payment accuracy, quality improvement, risk adjustment, and network performance management programs. The company also...
Cotiviti Holdings's Top Stability & Growth Strengths
Strong Market Position & Advantage: Independent analyst recognition places the company in the Leaders category for payment integrity, and the narrative emphasizes deep penetration among large U.S. health plans. The materials also describe broad pre- and post-pay capabilities and repeated shortlist presence versus major peers.
Investor Backing & Capital Strength: Ownership by Veritas Capital with KKR joining as co-owner at a large valuation is presented as a durability and stability signal for the platform. The recapitalization is also framed as funding for continued product and commercial expansion.
Product Line Growth: The acquisition of Edifecs is positioned as a meaningful expansion into interoperability and value-based care capabilities, broadening the platform beyond core payment integrity. Additional launches and adjacent recognitions are cited as ongoing portfolio build-out.
The Biddano initiative has sprung from a simple motive — to bring down the huge walls that separate the needful from the needy. Human health and well-being, as known, is a complex subject. We are here to mitigate every complexity and help people lead healthier lives. From the most critical topic to the remotest approach, We have evolved Healthcare Logistics...
As a strategic partner to some of the world’s largest healthcare organizations, we play a deep and meaningful role in accelerating digital innovation, driving sustainable value and helping improve outcomes across the healthcare ecosystem. With our deep healthcare domain knowledge and next-generation technology focus, we are well positioned to build digital capabilities and specialized platforms, enabling healthcare organizations reinvent themselves...
Avegen is a digital health platform scale-up. We build digital patient support solutions, digitised clinical workflows and digital therapeutics for our partners. We work with major pharmaceutical companies, research institutes and healthcare providers around the world and our products touch 2 million + patients managing long term conditions in infectious diseases, cardiovascular & metabolics, oncology, endocrinology, mental health and maternal...
Advantmed is a healthcare solutions company that empowers health plans and providers to succeed in value-based care by delivering tailored solutions in risk analytics, quality improvement, medical record retrieval, abstraction, coding, and in-home assessments.
At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 70 years, we have developed, built and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial...
Varian's Top Stability & Growth Strengths
Strong Market Position & Advantage: Industry analyses frequently describe external‑beam radiotherapy as a Varian–Elekta near‑duopoly, with Varian often cited at or near the top. Feedback suggests a large installed base, leading software stack, and a broad global service footprint reinforce this position.
Strong Revenue Growth: Company and trade updates state the Varian segment has posted year‑over‑year revenue growth across multiple recent periods within Siemens Healthineers, alongside positive order momentum and a growing backlog. Feedback suggests recent quarterly trends point to continued demand for systems, software, and services.
Strategic Partnerships: Integration with Siemens Healthineers provides access to imaging, diagnostics, and digital platforms, enabling end‑to‑end oncology workflows and cross‑selling advantages. Feedback suggests this parent‑level backing strengthens global reach and execution in tenders.
